“Pharmaceutical executives who recently made a major donation to an anti-marijuana legalization campaign claimed they were doing so out of concern for the safety of children — but their investor filings reveal that pot poses a direct threat to their plans to cash in on a synthetic cannabis product they have developed.”
Related Posts
Cannabis-based medicine may cut seizures in half
- WOCredentials
- April 19, 2017
- 0
“Taking cannabidiol may cut seizures in half for some children and adults with Lennox-Gastaut syndrome (LGS), a severe form of epilepsy”
Cannabinoids as novel anti-inflammatory drugs (2009)
- WOCredentials
- June 16, 2016
- 0
“It is becoming increasingly clear that cannabinoid receptors and their endogenous ligands play a crucial role in the regulation of the immune system. Exogenous cannabinoids have been shown to suppress […]
Cannabis induces a clinical response in patients with Crohn’s disease: a prospective placebo-controlled study (2013)
- WOCredentials
- September 19, 2016
- 0
“a short course (8 weeks) of THC-rich cannabis produced significant clinical, steroid-free benefits to 10 of 11 patients with active Crohn’s disease, compared with placebo, without side effects.” Naftali, T., […]